X0202 4 2007-03-22 0 0001167419 AspenBio Pharma, Inc. apnb 0001363399 1837 RMB Managers L.L.C. C/O RMB CAPITAL MANAGEMENT, LLC 10 S. WACKER DR. STE 3210 CHICAGO IL 60606 0 0 1 0 0001363397 1837 Partners L.P. C/O RMB CAPITAL MANAGEMENT, LLC 10 S. WACKER DR. STE 3210 CHICAGO IL 60606 0 0 1 0 0001376884 1837 Partners QP L.P. C/O RMB CAPITAL MANAGEMENT, LLC 10 S. WACKER DR. STE. 3210 CHICAGO IL 60606 0 0 1 0 AspenBio Pharma, Inc. 2007-03-22 4 P 0 19500 3.72 A 2338825 D AspenBio Pharma, Inc. 2007-03-23 4 P 0 208776 3.78 A 2547601 D These securities are directly owned by 1837 Partners L.P. and 1837 Partners QP L.P. ("Partnerships"). As the General Partner to the Partnerships, 1837 RMB Managers L.L.C., may be deemed to be the beneficial owner of the Issuer's securities held by the Parnterships. 1837 RMB Managers L.L.C. disclaims any beneficial ownership of any of the Issuer's securities reported herein for the purposes of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, or otherwise, except as to securities representing 1837 RMB Managers L.L.C.'s pro rata interest in the profits of the Partnerships. All 19,500 shares are allocated to 1837 Partners QP L.P. All 208,776 shares are allocated to 1837 Partners QP L.P. Richard M. Burridge, Jr. 2007-03-26